Hypoglycemia: How Low Is Too Low?

Low blood glucose, also called hypoglycaemia, can feel unsettling — often comprising dizziness, shakiness, or sudden sweating may catch you off guard. While GIP/GLP-1 agonists like tirzepatide are unlikely to cause hypoglycaemia on their own, the chance may rise when they’re combined with other diabetes treatments (if prescribed) like insulin. Understanding what to watch for, and how to respond, can make all the difference.

Signs to watch out for

Common warning signs of low blood glucose may include:

  • Dizziness or light-headedness
  • Shakiness or tremors
  • Sweating, even when it’s not hot
  • Sudden hunger or irritability

If left untreated, hypoglycaemia can become serious. That’s why recognizing early signs and having a plan is so important.

Simple ways to lower your risk

1. Keep quick sugar handy

Glucose tablets, juice boxes, or even a few pieces of hard candy can quickly bring your levels back up if they drop.

2. Don’t skip meals

Eating regular meals and snacks helps maintain balance. Remember to fuel up before and after exercise as well.

3. Stay connected with your healthcare team

If you notice frequent dips in your glucose, your prescriber may need to adjust your medications.

4. Monitor regularly

Whether you use a glucometer or a continuous glucose monitor, checking your glucose helps catch drops early and confirm low readings.

Conclusion

Hypoglycaemia may be uncommon with your weight management medication alone, but it’s something to keep in mind if you’re on multiple therapies especially certain glucose lowering drugs. Knowing the symptoms, keeping quick sugar increasing sources with you, and monitoring regularly can help you manage dips safely. If you’re unsure about what you’re experiencing, it’s always best to check in with your healthcare provider.

Disclaimers: This initiative is solely for patient support. It has been created with an intention to provide, assistance and support to patients & NOT intended towards product promotion, NOR advertisement of any health care professionals or doctors.  Patients should be advised to consult and seek medical advice from their concerned doctor/ health care professional before starting any treatment/medicine/ diet plan. Any advice regarding the management of any medical condition is completely at the discretion of their consulting physician/doctor (Registered Medical Practitioner). Cipla limited makes no representations as to the efficacy, accuracy, appropriateness, or suitability of any specific tests, products, procedures, treatments, services, opinions, healthcare providers or other information that may be shared through this screening/program/activity. Cipla shall not be responsible for any direct, indirect, consequential or other damages arising therefrom. No personal data is being collected, stored, or processed by Cipla as a part of this initiative. Yurpeak®, KwikPen® and Lilly are registered trademark of Eli Lilly & Company, promoted and distributed by Cipla in India. The “CIPLA” mark and logo are the sole and intellectual property of Cipla Limited. Nothing on this website should be construed as giving medical advice or making recommendations regarding any health-related decision or action. You should consult a doctor or other qualified healthcare professional regarding any questions about your health or before making any treatment-related decisions. The contents of this site are not intended to substitute the medical judgment of your treating physicians. This website is intended for people over 18 years of age. This website is intended for the sole use of registered health care providers and patients prescribed with Yurpeak (tirzepatide) on their physician's advice. Yurpeak and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. Yurpeak is available by prescription only. To be sold by retail under prescription of Endocrinologist or Internal Medicine specialists only. For adverse events and safety reporting, please reach out to: drugsafety@cipla.com or report to Cipla Ltd. on 18002577779 For any additional information related to Lilly products, please reach out to: queries_in-medinfo@lilly.com.